PENNY NORRIS: Open Payments
NPI 1427057504 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 12 payments from 6 companies in 2025. Trend: 2023 $959 · 2024 $618 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $121 |
| Novo Nordisk Inc | 3 | $67 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $49 |
| PFIZER INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: General - Therapies, LifeVest, Ozempic, ELIQUIS, Kerendia, Wegovy, ENTRESTO, LEQVIO.
Industry payments across IN — which companies pay providers there.
